Chyl-Surdacka K, Borzęcki A, Latifa J, Turska-Kozłowska M, Majchrzycka M. Keratosis follicularis (Darier disease) – clinical characteristics and treatment – a review and update. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(3):337-340. doi:10.5114/ada.2022.124344.
APA
Chyl-Surdacka, K., Borzęcki, A., Latifa, J., Turska-Kozłowska, M., & Majchrzycka, M. (2023). Keratosis follicularis (Darier disease) – clinical characteristics and treatment – a review and update. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(3), 337-340. https://doi.org/10.5114/ada.2022.124344
Chicago
Chyl-Surdacka, Katarzyna, Adam Borzęcki, Jakub Latifa, Monika Turska-Kozłowska, and Marianna Majchrzycka. 2023. "Keratosis follicularis (Darier disease) – clinical characteristics and treatment – a review and update". Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii 40 (3): 337-340. doi:10.5114/ada.2022.124344.
Harvard
Chyl-Surdacka, K., Borzęcki, A., Latifa, J., Turska-Kozłowska, M., and Majchrzycka, M. (2023). Keratosis follicularis (Darier disease) – clinical characteristics and treatment – a review and update. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, 40(3), pp.337-340. https://doi.org/10.5114/ada.2022.124344
MLA
Chyl-Surdacka, Katarzyna et al. "Keratosis follicularis (Darier disease) – clinical characteristics and treatment – a review and update." Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii, vol. 40, no. 3, 2023, pp. 337-340. doi:10.5114/ada.2022.124344.
Vancouver
Chyl-Surdacka K, Borzęcki A, Latifa J, Turska-Kozłowska M, Majchrzycka M. Keratosis follicularis (Darier disease) – clinical characteristics and treatment – a review and update. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2023;40(3):337-340. doi:10.5114/ada.2022.124344.
Darier disease is one of the most common genodermatoses. Although Darier disease was described in 1886, targeted therapies remain unknown. Current literature lacks specific guidelines for treatment of Darier disease. Treatment remains symptomatic and may be challenging for dermatologists. The aim of this article is to present clinical characteristics and treatment options. In a mild form of the disease with a small number of skin lesions, the symptoms can be reduced by the use of topical medications. Oral retinoids, alternatively doxycycline, seem to be beneficial in extensive and persistent lesions unresponsive to local treatment. In limited, hypertrophic forms, surgical methods, laser therapy and photodynamic therapy could be used.